Search

Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008.

… Wednesday, October 1, 2008 Summary Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008. Scott N. Keeney , a member of the Molecular Biology Program within

Memorial Sloan Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center, will provide leading-edge chemotherapy services to current MSKCC patients who live in or near Brooklyn - which amounts to more than 15 percent of MSKCC's patients currently being treated in Manhattan.

… Monday, September 13, 2010 Memorial Sloan Kettering Cancer Center (MSKCC) today celebrated a new outpatient chemotherapy center, which is scheduled to open later this month, pending approval from the State Department of Health. The 7,745-square-foot facility, called the Brooklyn Infusion Center , will

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.

… Monday, November 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s  Paul Marks Prize for Cancer Research . The prize, named in honor of MSK’s past President Emeritus, the late Paul Marks, MD, recognizes a new generation

MSK head and neck surgeons are investigating novel imaging methods that enable them to detect and visualize cancer cells during an operation.

… Thursday, August 17, 2017 Summary Surgery for head and neck cancers is challenging due to the presence of critical nerves and blood vessels near the tumors. MSK surgeons are exploring several new imaging techniques that detect and illuminate cancer cells during the operation. This will enable surgeons

Find out what it’s like to undergo cancer treatment when you work at a cancer hospital like Memorial Sloan Kettering.

… Monday, October 8, 2018 Summary As Director of Case Management at Memorial Sloan Kettering, Laura Ostrowsky oversees discharge planning and follow-up care for people leaving the hospital. She has held the role for 19 years. She was diagnosed with early-stage breast cancer in January 2018 and was treated

Following surgery to remove NF2 tumors in her brain, MSK patient Maggie Chess developed a sudden passion and talent for abstract painting, a rare outcome that has transformed her life.

… Wednesday, July 30, 2025 Maggie Chess holds a special place in her heart for the neurosurgeons at Memorial Sloan Kettering Cancer Center (MSK). Brain surgery at MSK, in 2021, saved Maggie’s life and gave her family much needed hope. But what makes Maggie’s case extraordinary is what she discovered post-surgery

Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center.

… Wednesday, December 1, 2021 Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from the Levine Cancer Center in North Carolina and succeeds C. Ola Landgren, MD, PhD, who previously served in this role for six years. Dr. Usmani is

Along with Valentine's Day, February marks American Heart Month. MSK’s Vice Chair of Radiation Oncology, Dr Oren Cahlon talks on how his team are making radiation-induced heart disease “a thing of the past” for our breast cancer patients.

… Tuesday, February 13, 2018

All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery.

… Monday, November 19, 2018 All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery. The results of our most recent analysis of planning data for 102 patients treated consecutively at Memorial

Memorial Sloan Kettering's Boards of Overseers and Managers have announced the creation of the Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chairs and have named the first two incumbents: Sloan Kettering Institute's Grégoire Altan-Bonnet and Songhai Shi.

… Wednesday, July 1, 2009 Summary Memorial Sloan Kettering’s Boards of Overseers and Managers have announced the creation of the Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chairs and have named the first two incumbents: Sloan Kettering Institute’s Grégoire Altan-Bonnet and Songhai Shi. Memorial